<p>(A) Representative microphotographs of tamoxifen sensitive, intermediate, and resistant tumor tissues with TUNEL, Ki-67, ERα, and ERβ staining, while the target cells were indicated with black arrows. (B) Apoptotic (TUNEL), (C) proliferative (Ki-67), (D) ERα-positive, and (E) ERβ-positive cell densities of the three groups. Statistical difference from resistant group is represented with asterisks above bars.</p
<p>A. ER-positive breast cancer MCF7 cells and tamoxifen resistant MCF7 cells (MCF7/TAM) cells were ...
Tamoxifen, a potent anticancer agent known to interrupt the enhanced estrogen activity of malignant ...
The aim of the study was to evaluate the immunohistochemical expression of cell proliferation and ap...
We developed a three-dimensional assay prepared from primary breast cancer tissue and quantified tum...
Background: It remains clinically important to identify ER positive breast cancers likely to respond...
<p>(A) Volume changes of tumors sensitive, intermediate, or resistant to tamoxifen over 32 days afte...
The purpose of the present study was to evaluate breast carcinoma samples before and two days after ...
<p>Tumor cell apoptosis (TUNEL, A and B), tumor microvascular density (CD31, C and D), and tumor cel...
<p>Tumor control (Ki67, A), low-dose FALHE treatment (Ki67, B), high-dose FALHE treatment (Ki67, C),...
In this study we demonstrate the change in estrogen receptor (ER) level and cell proliferation in hu...
Tamoxifen citrate (TAM) has been used to treat breast cancer in women for many years. The com-parati...
Abstract Tamoxifen (TMX) is used as adjuvant therapy for estrogen receptor-positive (ER+) breast can...
<p>Western blot analysis of the expression levels of ER-α66, ER-α36, HER2 and EGFR in ER-positive br...
Tamoxifen (TAM) is a non-steroidal anti-estrogen used to treat patients with estrogen receptor-posit...
Tamoxifen (TAM) is a non-steroidal anti-estrogen used to treat patients with estrogen receptor-posit...
<p>A. ER-positive breast cancer MCF7 cells and tamoxifen resistant MCF7 cells (MCF7/TAM) cells were ...
Tamoxifen, a potent anticancer agent known to interrupt the enhanced estrogen activity of malignant ...
The aim of the study was to evaluate the immunohistochemical expression of cell proliferation and ap...
We developed a three-dimensional assay prepared from primary breast cancer tissue and quantified tum...
Background: It remains clinically important to identify ER positive breast cancers likely to respond...
<p>(A) Volume changes of tumors sensitive, intermediate, or resistant to tamoxifen over 32 days afte...
The purpose of the present study was to evaluate breast carcinoma samples before and two days after ...
<p>Tumor cell apoptosis (TUNEL, A and B), tumor microvascular density (CD31, C and D), and tumor cel...
<p>Tumor control (Ki67, A), low-dose FALHE treatment (Ki67, B), high-dose FALHE treatment (Ki67, C),...
In this study we demonstrate the change in estrogen receptor (ER) level and cell proliferation in hu...
Tamoxifen citrate (TAM) has been used to treat breast cancer in women for many years. The com-parati...
Abstract Tamoxifen (TMX) is used as adjuvant therapy for estrogen receptor-positive (ER+) breast can...
<p>Western blot analysis of the expression levels of ER-α66, ER-α36, HER2 and EGFR in ER-positive br...
Tamoxifen (TAM) is a non-steroidal anti-estrogen used to treat patients with estrogen receptor-posit...
Tamoxifen (TAM) is a non-steroidal anti-estrogen used to treat patients with estrogen receptor-posit...
<p>A. ER-positive breast cancer MCF7 cells and tamoxifen resistant MCF7 cells (MCF7/TAM) cells were ...
Tamoxifen, a potent anticancer agent known to interrupt the enhanced estrogen activity of malignant ...
The aim of the study was to evaluate the immunohistochemical expression of cell proliferation and ap...